J Korean Med Sci.  2005 Dec;20(6):926-931. 10.3346/jkms.2005.20.6.926.

Leukotriene-related Gene Polymorphisms in Patients with Aspirin-intolerant Urticaria and Aspirin-intolerant Asthma: Differing Contributions of ALOX5 Polymorphism in Korean Population

  • 1Department of Allergy and Rheumatology, Ajou University School of Medicine, Suwon, Korea. hspark@ajou.ac.kr
  • 2Human Genetics Division, University of Southampton School of Medicine, Southampton, U.K.
  • 3Department of Statistics, Yonsei University, Seoul, Korea.
  • 4Asthma Genome Research Center, Soonchunhyang University, Bucheon, Korea.


The pathogenesis of aspirin (acetylsalicylic acid, ASA)-intolerant urticaria (AIU) is still poorly understood but it has recently been suggested that it is associated with the overproduction of leukotriene (LT). This is supported by evidence that cyclooxygenase 2 inhibitor is given safely to patients with AIU. The present study was designed to investigate the role of genetic polymorphism of LT related genes in the pathogenesis of AIU via a case-control study. We screened single nucleotide polymorphisms (SNPs) in genes encoding enzymes involved in leukotriene synthesis in the Korean population with AIU (n=101), ASA-intolerant asthma (AIA, n=95) and normal healthy controls (n=123). Genotype was determined by primer extension reactions using the SNapShot ddNTP primer extension kit. Among 8 SNPs of four LT related genes, the polymorphism of ALOX5 at positions of -1708 G>A showed significant difference in genotype frequency between AIU and AIA (p=0.01). Furthermore, there were significant differences observed in the frequencies of two ALOX5 haplotypes between the AIU group and AIA group (p<0.05). However, there were no differences in allele, genotype, or haplotype frequencies of ALOX5 between the AIU group and the normal control group. These results suggested that ALOX5 has a differing contribution in two major clinical pathogenesis related to ASA-sensitivity.


Aspirin, Hypersensitivity; Urticaria; Polymorphism, Genetic; Leukotrienes

MeSH Terms

Arachidonate 5-Lipoxygenase/*genetics
Aspirin/*adverse effects
Carrier Proteins/genetics
Case-Control Studies
Cyclooxygenase 2/genetics
Gene Frequency
Glutathione Transferase/genetics
Membrane Proteins/genetics
Middle Aged
Polymorphism, Single Nucleotide
Research Support, Non-U.S. Gov't

Cited by  1 articles

Complementary Participation of Genetics and Epigenetics in Development of NSAID-exacerbated Respiratory Disease
Jong-Uk Lee, Jong Sook Park, Hun Soo Chang, Choon-Sik Park
Allergy Asthma Immunol Res. 2019;11(6):779-794.    doi: 10.4168/aair.2019.11.6.779.


1. Grattan CE. Aspirin sensitivity and urticaria. Clin Exp Dermatol. 2003. 28:123–127.
2. Mastalerz L, Setkowicz M, Sanak M, Szczeklik A. Hypersensitivity to aspirin: Common eicosanoid alterations in urticaria and asthma. J Allergy Clin Immunol. 2004. 113:771–775.
3. Quiralte J, Blanco C, Castillo R, Ortega N, Carrillo T. Anaphylactoid reactions due to nonsteroidal antiinflammatory drugs: clinical and cross-reactivity studies. Ann Allergy Asthma Immunol. 1997. 78:293–296.
4. Christie PE, Tagari P, Ford-Hutchinson AW, Black C, Markendorf A, Schmitz-Schumann M, Lee TH. Urinary leukotriene E4 after lysine-aspirin inhalation in asthmatic subjects. Am Rev Respir Dis. 1992. 146:1531–1534.
5. Smith CM, Hawksworth RJ, Thien FC, Christie PE, Lee TH. Urinary leukotriene E4 in bronchial asthma. Eur Respir J. 1992. 5:693–699.
6. Holgate ST, Sampson AP. Antileukotriene therapy. Future directions. Am J Respir Crit Care Med. 2000. 161:147–153.
7. Drazen JM, Israel E, O'Byme PM. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med. 1999. 340:197–206.
8. Doeglas HM. Reactions to aspirin and food additives in patients with chronic urticaria, including the physical urticarias. Br J Dermatol. 1975. 93:135–144.
9. Stevenson DD, Simon RA. Middleton E, Reed CE, Ellis EF, editors. Sensitivity to aspirin and nonsteroidal anti-inflammatory drugs. Allergy: Principles and Practice. 1993. 4th edn. Mosby;1747–1765.
10. Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med. 1990. 323:645–655.
11. Erbagci Z. The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study. J Allergy Clin Immunol. 2002. 110:484–488.
12. Pacor ML, Di Lorenzo G, Corrocher R. Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid. Clin Exp Allergy. 2001. 31:1607–1614.
13. Ellis MH. Successful treatment of chronic urticaria with leukotriene antagonists. J Allergy Clin Immunol. 1998. 102:876–877.
14. Perez C, Sanchez-Borges M, Capriles E. Pretreatment with montelukast blocks NSAID-induced urticaria and angioedema. J Allergy Clin Immunol. 2001. 108:1060–1061.
15. Zembowicz A, Mastalerz L, Setkowicz M, Radziszewski W, Szczeklik A. Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs. Arch Dermatol. 2003. 139:1577–1582.
16. Quiralte J, Saenz de San Pedro B, Florido JJ. Safety of selective cyclooxygenase-2 inhibitor rofecoxib in patients with NSAID-induced cutaneous reactions. Ann Allergy Asthma Immunol. 2002. 89:63–66.
17. Choi JH, Park HS, Oh HB, Lee JH, Suh YJ, Park CS, Shin HD. Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase. Hum Genet. 2004. 114:337–344.
18. Sanak M, Simon HU, Szczeklik A. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet. 1997. 350:1599–1600.
19. Sanak M, Pierzchalska M, Bazan-Socha S, Szczeklik A. Enhanced expression of the leukotriene C(4) synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma. Am J Respir Cell Mol Biol. 2000. 23:290–296.
20. Sanchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F. Cutaneous reactions to aspirin and nonsteroidal anti-inflammatory drugs. Clin Rev Allergy Immunol. 2003. 24:125–136.
21. Park HS. Early and late onset asthmatic responses following lysineaspirin inhalation in aspirin-sensitive asthmatic patients. Clin Exp Allergy. 1995. 25:38–40.
22. Schunck B, Kraft W, Truyen U. A simple touch-down polymerase chain reaction for the detection of canine parvovirus and feline panleukopenia virus in feces. J Virol Methods. 1995. 55:427–433.
23. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005. 21:263–265.
24. Sayers I, Barton S, Rorke S, Sawyer J, Peng Q, Beghe B, Ye S, Keith T, Clough JB, Holloway JW, Sampson AP, Holgate ST. Promoter polymorphism in the 5-lipoxygenase (ALOX5) and 5-lipoxygenase-activating protein (ALOX5AP) genes and asthma susceptibility in a Caucasian population. Clin Exp Allergy. 2003. 33:1103–1110.
25. Sayers I, Barton S, Rorke S, Beghe B, Hayward B, Van Eerdewegh P, Keith T, Clough JB, Ye S, Holloway JW, Sampson AP, Holgate ST. Allelic association and functional studies of promoter polymorphism in the Leukotriene C4 synthase gene (LTC4S) in asthma. Thorax. 2003. 58:417–424.
26. Nizankowska E, Bestynska-Krypel A, Cmiel A, Szczeklik A. Oral and bronchial provocation tests with aspirin for diagnosis of aspirininduced asthma. Eur Respir J. 2000. 15:863–869.
Full Text Links
  • JKMS
export Copy
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr